1 / 26

MLAB 1415- Hematology Keri Brophy-Martinez

MLAB 1415- Hematology Keri Brophy-Martinez. Chapter 9: Iron Metabolism and Hypochromic Anemias. Iron Metabolism. Primary function Oxygen transport and storage Distribution Types of iron-containing compounds Functional, assisting in enzymatic and metabolic functions

donnel
Download Presentation

MLAB 1415- Hematology Keri Brophy-Martinez

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MLAB 1415- HematologyKeri Brophy-Martinez Chapter 9: Iron Metabolism and Hypochromic Anemias

  2. Iron Metabolism • Primary function • Oxygen transport and storage • Distribution • Types of iron-containing compounds • Functional, assisting in enzymatic and metabolic functions • Transportation or storage • Location • RBCs- majority here • Macrophages of spleen& liver- where destruction of RBC occurs, liberating iron • Hepatocytes and enterocytes- storage of iron

  3. Iron Metabolism • Iron absorption and storage is influenced by: • The amount and type of available iron in the diet • Is it a nutritional deficiency • Incomplete absorption due to GI tract problems • Current iron stores • Increased demand (pregnancy, the growth years) • Excessive loss due to acute or chronic hemorrhage • menstrual period for women of childbearing years, GI bleeding for men

  4. Forms of Iron • Nonheme • Ionic or ferric • Found in vegetables and whole grains • Heme • Found in red meats • Easily absorbed

  5. Iron Metabolism • Transport • Transferrin • Transports iron to bone marrow to be used in hgb synthesis • Synthesized in the liver • Storage • Primarily in the liver • Ferritin • Soluble iron, quick release for heme synthesis • Hemosiderin • Partially degraded iron, slow release

  6. Iron Balance • Loss of iron • Secretions of urine, bile , sweat and exfoliation of intestinal epithelial cells of GI tract • Approx. 1 mg/ day • Regulation of iron • Delicate balance between loss and absorption

  7. Laboratory Assessment of Iron • Serum iron • Total iron binding capacity (TIBC) • Percent saturation • Serum ferritin

  8. Clinical Syndromes of Iron Metabolism • Iron Deficiency Anemia (IDA) • AKA Sideropenic anemia • This is the most common form of anemia. • IDA occurs when the iron stores in the body are inadequate to preserve homeostasis.

  9. Causes of IDA • Dietary • Blood Loss • Hemodialysis • Malabsorption

  10. 3 Stages of IDA • Stage 1 • Decrease in storage iron (ferritin decrease) • No anemia • RBC morphology normal • RDW can be elevated • Stage 2 • Decrease in iron for erythropoiesis • No anemia or hypochromia • RBC slightly microcytic • Stage 3 • Decrease in Blood Hgb • Decrease in peripheral tissue oxygen delivery • All lab tests abnormal • Microcytic, hypochromic anemia

  11. Clinical Features of IDA • SOB • Lethargy • Pallor • Gastritis • Pica • Koilonychia

  12. IDA: Lab features • Decreased • RBC, Hgb, Hct, MCV, MCH, MCHC • Normal to decreased • Retic • Peripheral blood smear • microcytic-hypochromic • Targets, elliptocytes, teardrops • If IDA is caused by bleeding, leukocytosis and thrombocytosis are possible.

  13. IDA: Lab Findings • Bone marrow • Decrease in stainable iron • Decrease in erythroid hyperplasia • M:E ratio decreased • Chemistry • Decrease in serum iron and ferritin • Increased TIBC

  14. Anemia of Chronic Disease (ACD) • Anemia that occurs in patients with chronic infections, chronic inflammatory disorders, trauma, organ failure or neoplasms • Occurs due to biochemical changes during inflammation • Hallmark is normal iron stores but low serum iron

  15. Anemia of Chronic Disease • Mechanisms • Block in release of iron from macrophages due to increased cytokines • Cytokine inhibition of EPO production • Cytokine inhibition of erythropoiesis • Shortened erythrocyte survival

  16. ACD: Lab Features • Typical lab findings • Decreased • RBC, Hgb, Hct, MCV, MCH, serum iron • Increased • ferritin • Normal • MCHC • Normal to decreased • Retic, TIBC • Peripheral blood smear • normocytic-normochromic • Targets, elliptocytes, teardrops • Bone marrow • M:E ratio increased

  17. Anemia’s Associated with Abnormal Heme Synthesis • Sideroblastic Anemia • Lead Poisoning • Porphyrias

  18. Sideroblastic Anemia (SA) • First step in heme synthesis is affected • Characterized by: • Increase in total body iron • Presence of ringed sideroblasts in bone marrow • Hypochromic anemia

  19. Sideroblastic anemia • Classification • Hereditary • Acquired • 2 Forms • Idiopathic • Secondary type • Certain therapeutic drugs • Chronic transfusions (for aplastic anemia, leukemia, thalassemia) • Alcoholism and food fads • Use of iron utensils or increased iron in water .

  20. Sideroblastic anemia • Mechanism • Adequate iron but it can not be incorporated into hgb synthesis. • Iron enters mitochrondria of metarubricyte, but accumulates leading to formation of ringed sideroblasts • Eventually, mitochrondria rupture

  21. Lead poisoning • Lead interferes with iron storage in the mitochondria • Lead damages the activity of enzymes used for heme synthesis • Basophilic stippling pronounced

  22. Lead Poisoning

  23. Lab features of SA • Peripheral blood • Pappenheimer bodies • Hypochromic, normochromic RBCs • Normal to increased platelets • Chemistry • Increased serum iron, ferritin

  24. Hemochromatosis • Condition caused by increased iron absorption which deposits in vital organs such as the liver, spleen and pancreas which then becomes fibrotic • Hyperpigmentation of skin • Therapy consists of iron removal by therapeutic phlebotomy or chelation

  25. Porphyrias • Excessive production of porphyrins in the bone marrow (or liver) • Rare disease caused by accumulation of porphyrins in developing RBC’s • Defect in one or more of the enzymes in heme synthesis pathway • Characterized by dermal photosensitivity and rash caused by the sun. The original werewolf was probably a person with erythropoietic porphyria.

  26. References • Harmening, D. M. (2009). Clinical Hematology and Fundamentals of Hemostasis. Philadelphia: F.A Davis. • McKenzie, S. B., & Williams, J. L. (2010). Clinical Laboratory Hematology . Upper Saddle River: Pearson Education, Inc. • http://healthmap.wordpress.com/2008/11/

More Related